A Phase II trial of combination gemcitabine, carboplatin with or without trastuzumab in patients with metastatic breast cancer
Latest Information Update: 03 Nov 2021
Price :
$35 *
At a glance
- Drugs Trastuzumab (Primary) ; Carboplatin; Gemcitabine
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 02 May 2011 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
- 02 May 2011 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
- 15 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.